ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS
· Delayed Price · Currency is USD
0.140
0.00 (0.00%)
At close: Dec 5, 2025
ZyVersa Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 0.53 | 1.53 | 3.14 | 5.9 | 0.33 | 0.17 |
| Cash & Short-Term Investments | 0.53 | 1.53 | 3.14 | 5.9 | 0.33 | 0.17 |
| Cash Growth | 329.53% | -51.21% | -46.84% | 1696.27% | 88.11% | - |
| Prepaid Expenses | 0.3 | 0.18 | 0.22 | 0.23 | 0.11 | 0.16 |
| Other Current Assets | 0.17 | - | - | 0.24 | 0.38 | - |
| Total Current Assets | 1 | 1.72 | 3.35 | 6.36 | 0.81 | 0.34 |
| Property, Plant & Equipment | - | - | 0.01 | 0.12 | 0.03 | 0.04 |
| Goodwill | - | - | - | 11.9 | - | - |
| Other Intangible Assets | - | 18.65 | 18.65 | 100.09 | - | - |
| Long-Term Deferred Charges | 0.04 | 0.06 | - | - | - | - |
| Other Long-Term Assets | - | 0.18 | 0.1 | 0.05 | 0.29 | 0.31 |
| Total Assets | 1.04 | 20.6 | 22.11 | 118.51 | 1.13 | 0.69 |
| Accounts Payable | 9.81 | 9.34 | 8.43 | 6.03 | 2 | 2.31 |
| Accrued Expenses | 2.95 | 1.89 | 1.25 | 0.8 | 0.75 | 1.16 |
| Current Portion of Long-Term Debt | - | - | - | - | 9.15 | 2.13 |
| Current Portion of Leases | - | - | 0.01 | 0.11 | - | - |
| Current Income Taxes Payable | - | - | - | 0.11 | - | - |
| Other Current Liabilities | 0.01 | 0.01 | 0.51 | 1.15 | 1.73 | 1.96 |
| Total Current Liabilities | 12.77 | 11.23 | 10.19 | 8.19 | 13.63 | 7.56 |
| Long-Term Debt | - | - | - | - | - | 1.69 |
| Long-Term Deferred Tax Liabilities | - | 0.85 | 0.84 | 10.32 | - | - |
| Other Long-Term Liabilities | - | - | - | 0.33 | 0.33 | 0.33 |
| Total Liabilities | 12.77 | 12.08 | 11.04 | 18.84 | 13.96 | 9.57 |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 125.19 | 121.16 | 114.3 | 104.58 | 40.07 | 35.92 |
| Retained Earnings | -136.91 | -112.63 | -103.22 | -4.92 | -52.9 | -44.81 |
| Treasury Stock | -0.01 | -0.01 | -0.01 | - | - | - |
| Total Common Equity | -11.73 | 8.52 | 11.07 | 99.66 | -12.83 | -8.89 |
| Shareholders' Equity | -11.73 | 8.52 | 11.07 | 99.66 | -12.83 | -8.89 |
| Total Liabilities & Equity | 1.04 | 20.6 | 22.11 | 118.51 | 1.13 | 0.69 |
| Total Debt | - | - | 0.01 | 0.11 | 9.15 | 3.82 |
| Net Cash (Debt) | 0.53 | 1.53 | 3.13 | 5.79 | -8.82 | -3.64 |
| Net Cash Growth | 329.53% | -51.07% | -45.99% | - | - | - |
| Net Cash Per Share | 0.12 | 1.38 | 32.09 | 0.25 | -3.65 | -53.94 |
| Filing Date Shares Outstanding | 8.1 | 2.57 | 0.83 | 0.12 | 24.17 | 0.07 |
| Total Common Shares Outstanding | 8.1 | 2.51 | 0.41 | 0.03 | 24.17 | 0.07 |
| Working Capital | -11.77 | -9.52 | -6.84 | -1.83 | -12.81 | -7.22 |
| Book Value Per Share | -1.45 | 3.40 | 27.33 | 3868.91 | -0.53 | -131.63 |
| Tangible Book Value | -11.73 | -10.13 | -7.57 | -12.32 | -12.83 | -8.89 |
| Tangible Book Value Per Share | -1.45 | -4.04 | -18.69 | -478.20 | -0.53 | -131.63 |
| Machinery | - | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Source: S&P Capital IQ. Standard template. Financial Sources.